Heat Shock Protein 27 Immune Complex Altered Signaling and Transport (ICAST): Novel Mechanisms of Attenuating Inflammation
Abstract
Blood levels of heat shock protein (HSP27) and natural IgG auto-antibodies to HSP27 (AAbs) are higher in healthy controls compared to cardiovascular disease patients. Vaccination of mice with recombinant HSP25 (rHSP25, murine ortholog of human rHSP27) increased AAb levels, attenuated atherogenesis and reduced plaque inflammation and cholesterol content. We sought to determine if the HSP27 immune complex (IC) altered MΦ inflammation signaling (Toll Like Receptor 4; TLR4), and scavenger receptors involved in cholesterol uptake (SR-AI, CD-36). Combining a validated polyclonal IgG anti-HSP27 antibody (PAb) with rHSP27 enhanced binding to THP-1 MΦ cell membranes and activation of NF-κB signaling via TLR4, competing away LPS and effecting an anti-inflammatory cytokine profile. Similarly, adding the PAb with rHSP27 enhanced binding to SR-AI and CD-36, as well as lowered oxLDL binding in HEK293 cells separately transfected with SR-AI and CD-36, or THP-1 MΦ. Finally, the PAb enhanced the uptake and internalization of rHSP27 in THP-1 MΦ. Thus, the HSP27 IC potentiates HSP27 cell membrane signaling with receptors involved in modulating inflammation and cholesterol uptake, as well as HSP27 internalization. Going forward, we will explore HSP27 Immune Complex Altered Signaling and Transport (ICAST) as a new anti-inflammatory therapeutic strategy in vivo.Competing Interest StatementEOB is the inventor on US Provisional Patent Application (serial number: 63/031,640). EOB is the Scientific Co-Founder of Pemi31 Therapeutics Inc., a startup company that controls the aforementioned intellectual property. EOB, CS and YXC have equity interests in Pemi31 Therapeutics Inc.Nonstandard AbbreviationsAAbanti-HSP27 (or anti-HSP25) antibodiesApoE-/-apolipoprotein E nulla.u.absorbance unitsBSAbovine serum albuminHSPheat shock proteinHSP27Heat Shock Protein 27IL-10interleukin-10IL-1βinterleukin-1 betaLDLlow density lipoprotein cholesterolLDLRlow density lipoprotein receptorNF-κBnuclear factor kappa light chain enhancer of activated B cellsONovernightoxLDLoxidized LDLPBSphosphate buffered salinePBSTPBS tweenrC1recombinant C-terminal truncation of HSP27 spanning amino acids 90-205rHSP27recombinant HSP27Strep-HRTstreptavidin-horse radish peroxidaseTLR-4toll-like receptor 4TMB3,3′,5,5′-tetramethylbenzidineView Full Text
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heat Shock Protein 27 Immune Complex Upregulates LDLR Expression Thereby Reducing Plasma Cholesterol and Atherogenesis
Y.-X. Chen, C. Shi, … E. R. O'Brien·bioRxiv·May 21, 2020
- Lipopolysaccharide stimulation of RAW264.7 cells is a model for identifying novel clients of Hsc70
J. F. Rakus, N. R. Kegley, … M. Takeuchi·bioRxiv·May 15, 2020
- Innate extracellular Hsp70 inflammatory properties are mediated by the interaction of Siglec-E and LOX-1 receptors
Thiago J. Borges, Karina Rodrigues Lima, … Stuart K. Calderwood·Cell Stress and ChaperonesPeer-reviewed·May 22, 2025
- A CD25-CCR7 complex initiates non-canonical IL-2 signaling
Sarah Hyun Ji Kim, Ho-Sup Lee, … Mark H. Ginsberg·bioRxiv·Feb 3, 2025
- Heat Shock Protein 27 versus Estrogen Therapy for Post-Menopausal Atherosclerosis: Rethinking Mechanisms of Cholesterol Lowering
N. Maarouf, Y.-X. Chen, … E. R. O'Brien·bioRxiv·Jun 4, 2020
- Immunoproteasomal Processing of Isolevuglandin Adducts in Hypertension
N. de la Visitacion, W. Chen, … D. M. Patrick·Circulation ResearchPeer-reviewed·May 10, 2024